ADVANCED TUMORS
Clinical trials for ADVANCED TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare tumors: tarlatamab trial opens
Disease control Recruiting nowThis study tests the drug tarlatamab in people with advanced tumors that have a protein called DLL3. The goal is to see if the drug can shrink or control these tumors. About 29 adults with stage IV cancer will receive tarlatamab, and researchers will track how well it works and a…
Matched conditions: ADVANCED TUMORS
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New pill shows early promise against tough cancers
Disease control Recruiting nowThis early-stage study is testing a new oral drug called CS23546 in about 156 adults with advanced solid tumors or lymphoma that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see how the body processes it. Resear…
Matched conditions: ADVANCED TUMORS
Phase: PHASE1 • Sponsor: Chipscreen Biosciences, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New drug MDX2004 targets advanced tumors in early trial
Disease control Recruiting nowThis study tests a new drug, MDX2004, in 235 adults with advanced solid tumors that have spread or cannot be removed. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. Participants must be 18 or older, in good daily function, and have …
Matched conditions: ADVANCED TUMORS
Phase: PHASE1, PHASE2 • Sponsor: ModeX Therapeutics, An OPKO Health Company • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New drug SIBP-A10 tested in patients with advanced cancer
Disease control Recruiting nowThis early-phase trial tests a new drug called SIBP-A10 in 160 adults with advanced tumors that have not responded to other treatments. The main goal is to check the drug's safety and find the best dose for future studies. Participants will receive the drug and be monitored for s…
Matched conditions: ADVANCED TUMORS
Phase: PHASE1 • Sponsor: Shanghai Institute Of Biological Products • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New cancer drug AL58805 enters first human tests
Disease control Recruiting nowThis early-stage trial is testing an oral drug called AL58805 in 40 people with advanced solid tumors who have run out of standard treatment options. The main goals are to find a safe dose, identify side effects, and understand how the drug moves through the body. Researchers wil…
Matched conditions: ADVANCED TUMORS
Phase: PHASE1 • Sponsor: Advenchen Laboratories Nanjing Ltd. • Aim: Disease control
Last updated Jun 26, 2026 17:34 UTC